日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Higher Vedolizumab Clearance Associates with Poor Therapeutic Outcomes during Intravenous Vedolizumab Maintenance Therapy in Crohn's Disease

克罗恩病患者接受静脉注射维多珠单抗维持治疗期间,较高的维多珠单抗清除率与较差的治疗效果相关。

Anjie, Suzanne I; D'Haens, Geert R; Baert, Filip; Bossuyt, Peter; Hoentjen, Frank; Clasquin, Esmé; Molnár, Tamás; Löwenberg, Mark; Vermeire, Séverine; Panetta, J Carl; Dervieux, Thierry

Corrigendum to 'Superhuman performance on urology board questions using an explainable language model enhanced with European Association of Urology guidelines': [ESMO Real World Data and Digital Oncology, Volume 6, December 2024, 100078]

对“使用可解释语言模型结合欧洲泌尿外科协会指南,在泌尿外科考试题上取得超人般的表现”的更正:[ESMO 真实世界数据和数字肿瘤学,第 6 卷,2024 年 12 月,100078]

Hetz, M J; Carl, N; Haggenmüller, S; Wies, C; Kather, J N; Michel, M S; Wessels, F; Brinker, T J

Multi-omic profiling provides insights into the heterogeneity, microenvironmental features, and biomarker landscape of small-cell lung cancer

多组学分析能够深入了解小细胞肺癌的异质性、微环境特征和生物标志物图谱。

Xie, Mingchao; Vuko, Miljenka; Saran, Shashank; Liu, Siyu; Chambers, Andrew G; Baakza, Hana; Angell, Helen K; Ng, Felicia; Gay, Carl M; Cardnell, Robert J; Segerer, Felix J; Andoni, Alma; Rodriguez-Canales, Jaime; Waring, Paul M; Schick, Markus; Barrett, J Carl; Byers, Lauren A; Fabbri, Giulia

H&E-based MSI/MMR testing with AI in colorectal cancer: a multi-centred blinded evaluation

基于H&E染色的MSI/MMR检测结合人工智能在结直肠癌中的应用:一项多中心盲法评估

Bass, Cher; Ntelemis, Foivos; Schmidt, Julian; Wolf, Steffen; Geraldes, André; Mehrotra, Debapriya; Singhal, Shikha; Kumar, Narender; Marcia, Angelica; Bennett, Nicholas; Maiques, Oscar; Hyde, Mitchell; Mistry, Bejal; Rogerson, Grace; Cummings, Michele; Freer, Clare; Walsh, Elizabeth; Salto-Tellez, Manuel; Loughrey, Maurice; Um, In Hwa; Harrison, David J; Clarkson, Richard; Blackwood, James; Barrett, J Carl; Kather, Jakob Nikolas; Orsi, Nicolas M; Pandya, Pahini; Arslan, Salim

An artificial intelligence-based model for prediction of clonal hematopoiesis variants in cell-free DNA samples

基于人工智能的无细胞DNA样本克隆性造血变异预测模型

Arango-Argoty, Gustavo; Haghighi, Marzieh; Sun, Gerald J; Choe, Elizabeth Y; Markovets, Aleksandra; Barrett, J Carl; Lai, Zhongwu; Jacob, Etai

Variability of Circulating Tumor DNA Levels in Plasma Samples From Patients With Advanced Non-Small-Cell Lung Cancer in the Absence of Treatment

晚期非小细胞肺癌患者未接受治疗时血浆样本中循环肿瘤DNA水平的变异性

Markovets, Aleksandra; Merino Vega, Diana; Abbosh, Chris; Quinn, Katie; Chang, Kyle; Wienke, Sara; Hartmaier, Ryan; Barrett, J Carl; Hodgson, Darren

Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

非小细胞肺癌获得性免疫治疗耐药的临床和分子特征

Danish Memon ,Adam J Schoenfeld ,Darwin Ye ,George Fromm ,Hira Rizvi ,Xiang Zhang ,Mohamed Reda Keddar ,Divij Mathew ,Kyung Jin Yoo ,Jingya Qiu ,Jayon Lihm ,Jayalaksmi Miriyala ,Jennifer L Sauter ,Jia Luo ,Andrew Chow ,Umesh K Bhanot ,Caroline McCarthy ,Chad M Vanderbilt ,Cailian Liu ,Mohsen Abu-Akeel ,Andrew J Plodkowski ,Nicholas McGranahan ,Marta Łuksza ,Benjamin D Greenbaum ,Taha Merghoub ,Ikbel Achour ,J Carl Barrett ,Ross Stewart ,Pedro Beltrao ,Taylor H Schreiber ,Andy J Minn ,Martin L Miller ,Matthew D Hellmann

Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study

广泛期小细胞肺癌的分子分类和免疫治疗结果的生物标志物:CASPIAN 3 期研究分析

Mingchao Xie, Miljenka Vuko, Jaime Rodriguez-Canales, Johannes Zimmermann, Markus Schick, Cathy O'Brien, Luis Paz-Ares, Jonathan W Goldman, Marina Chiara Garassino, Carl M Gay, John V Heymach, Haiyi Jiang, J Carl Barrett, Ross A Stewart, Zhongwu Lai, Lauren A Byers, Charles M Rudin, Yashaswi Shresth

Skeletal muscle from TBC1D4 p.Arg684Ter variant carriers is severely insulin resistant but exhibits normal metabolic responses during exercise

TBC1D4 p.Arg684Ter 变异携带者的骨骼肌存在严重的胰岛素抵抗,但在运动过程中表现出正常的代谢反应。

Kristensen, Jonas M; Kjøbsted, Rasmus; Larsen, Trine J; Carl, Christian S; Hingst, Janne R; Onslev, Johan; Birk, Jesper B; Thorup, Anette; Steenberg, Dorte E; Knudsen, Jonas R; Henriksen, Nicolai S; Needham, Elise J; Halling, Jens F; Gudiksen, Anders; Rundsten, Carsten F; Hanghøj, Kristian E; Stinson, Sara E; Hoier, Birgitte; Hansen, Camilla C; Jensen, Thomas E; Hellsten, Ylva; Pilegaard, Henriette; Grarup, Niels; Olesen, Jesper; Humphrey, Sean J; James, David E; Pedersen, Michael L; Richter, Erik A; Hansen, Torben; Jørgensen, Marit E; Wojtaszewski, Jørgen F P

The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment

ATR抑制剂ceralasertib通过调节肿瘤微环境增强癌症检查点免疫疗法的疗效。

Elizabeth L Hardaker # ,Emilio Sanseviero # ,Ankur Karmokar # ,Devon Taylor # ,Marta Milo ,Chrysis Michaloglou ,Adina Hughes ,Mimi Mai ,Matthew King ,Anisha Solanki ,Lukasz Magiera ,Ricardo Miragaia ,Gozde Kar ,Nathan Standifer ,Michael Surace ,Shaan Gill ,Alison Peter ,Sara Talbot ,Sehmus Tohumeken ,Henderson Fryer ,Ali Mostafa ,Kathy Mulgrew ,Carolyn Lam ,Scott Hoffmann ,Daniel Sutton ,Larissa Carnevalli ,Fernando J Calero-Nieto ,Gemma N Jones ,Andrew J Pierce ,Zena Wilson ,David Campbell ,Lynet Nyoni ,Carla P Martins ,Tamara Baker ,Gilberto Serrano de Almeida ,Zainab Ramlaoui ,Abdel Bidar ,Benjamin Phillips ,Joseph Boland ,Sonia Iyer ,J Carl Barrett ,Arsene-Bienvenu Loembé ,Serge Y Fuchs ,Umamaheswar Duvvuri ,Pei-Jen Lou ,Melonie A Nance ,Carlos Alberto Gomez Roca ,Elaine Cadogan ,Susan E Critichlow ,Steven Fawell ,Mark Cobbold ,Emma Dean ,Viia Valge-Archer ,Alan Lau ,Dmitry I Gabrilovich ,Simon T Barry